Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Healthcare Sector Analysis

UpdatedJan 27, 2025
DataAggregated Company Financials
Companies35
  • 7D2.7%
  • 3M-0.2%
  • 1Y8.3%
  • YTD5.8%

In the last week, the Healthcare industry is up 3.1%, with Roche Holding up 3.6%. This means that the industry has gained 8.4% over the past year. Looking forward, earnings are forecast to grow by 13% annually.

Sector Valuation and Performance

Has the Swiss Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 Jan 2025CHF 604.1bCHF 152.7bCHF 24.5b31.1x24.6x4x
Wed, 25 Dec 2024CHF 562.0bCHF 152.3bCHF 24.5b28.4x23x3.7x
Fri, 22 Nov 2024CHF 568.4bCHF 151.3bCHF 24.3b29.3x23.4x3.8x
Sun, 20 Oct 2024CHF 618.7bCHF 148.5bCHF 22.6b31.2x27.4x4.2x
Tue, 17 Sep 2024CHF 603.6bCHF 147.0bCHF 22.3b32.6x27.1x4.1x
Thu, 15 Aug 2024CHF 614.7bCHF 148.1bCHF 22.3b31.8x27.6x4.2x
Sat, 13 Jul 2024CHF 595.8bCHF 148.7bCHF 22.7b37.8x26.3x4x
Mon, 10 Jun 2024CHF 572.5bCHF 148.9bCHF 22.7b35.4x25.2x3.8x
Wed, 08 May 2024CHF 537.2bCHF 145.9bCHF 22.8b32.7x23.5x3.7x
Fri, 05 Apr 2024CHF 553.0bCHF 144.4bCHF 22.2b35.7x24.9x3.8x
Sun, 03 Mar 2024CHF 531.8bCHF 143.2bCHF 22.7b36.4x23.5x3.7x
Tue, 30 Jan 2024CHF 546.6bCHF 152.0bCHF 21.9b28x25x3.6x
Thu, 28 Dec 2023CHF 520.3bCHF 150.6bCHF 21.7b26.2x24x3.5x
Sat, 25 Nov 2023CHF 516.0bCHF 153.6bCHF 22.0b24.8x23.4x3.4x
Mon, 23 Oct 2023CHF 505.6bCHF 153.2bCHF 21.6b25.7x23.4x3.3x
Wed, 20 Sep 2023CHF 539.7bCHF 145.0bCHF 21.1b32.6x25.6x3.7x
Fri, 18 Aug 2023CHF 542.4bCHF 143.9bCHF 21.1b31.1x25.7x3.8x
Sun, 16 Jul 2023CHF 553.9bCHF 145.1bCHF 22.0b36.1x25.2x3.8x
Tue, 13 Jun 2023CHF 574.3bCHF 148.0bCHF 22.3b34.3x25.7x3.9x
Thu, 11 May 2023CHF 579.7bCHF 146.9bCHF 22.3b32.7x26x3.9x
Sat, 08 Apr 2023CHF 574.6bCHF 147.3bCHF 22.4b33.1x25.6x3.9x
Mon, 06 Mar 2023CHF 541.3bCHF 148.8bCHF 22.6b31.7x24x3.6x
Wed, 01 Feb 2023CHF 576.0bCHF 149.5bCHF 38.6b31.3x14.9x3.9x
Fri, 30 Dec 2022CHF 562.7bCHF 148.4bCHF 38.0b30.1x14.8x3.8x
Sun, 27 Nov 2022CHF 580.5bCHF 149.8bCHF 38.5b34.4x15.1x3.9x
Tue, 25 Oct 2022CHF 569.2bCHF 153.5bCHF 40.9b26.2x13.9x3.7x
Thu, 22 Sep 2022CHF 557.5bCHF 151.1bCHF 39.9b29.5x14x3.7x
Sat, 20 Aug 2022CHF 594.6bCHF 150.2bCHF 39.7b30.6x15x4x
Mon, 18 Jul 2022CHF 608.3bCHF 149.7bCHF 40.7b33.2x14.9x4.1x
Wed, 15 Jun 2022CHF 570.5bCHF 151.1bCHF 41.3b29.6x13.8x3.8x
Fri, 13 May 2022CHF 606.9bCHF 150.1bCHF 40.9b34.1x14.8x4x
Sun, 10 Apr 2022CHF 696.1bCHF 146.0bCHF 39.2b39.9x17.7x4.8x
Tue, 08 Mar 2022CHF 612.6bCHF 145.0bCHF 39.0b31.7x15.7x4.2x
Thu, 03 Feb 2022CHF 648.0bCHF 139.7bCHF 25.3b46.4x25.6x4.6x
Price to Earnings Ratio

25.6x


Total Market Cap: CHF 648.0bTotal Earnings: CHF 25.3bTotal Revenue: CHF 139.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Sector Price to Earnings3Y Average 21.7x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 24.6x which is higher than its 3-year average PE of 21.7x.
  • The industry is trading close to its 3-year average PS ratio of 3.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 2.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare sector?

CH Market2.07%
Healthcare2.74%
Life Sciences4.63%
Medical Equipment3.97%
Pharma2.31%
Healthcare Services0.87%
Biotech-0.94%
Healthtech-21.69%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 45.7x.
    • Analysts are expecting annual earnings growth of 20.4%, which is higher than its past year's earnings growth of 4.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings growth rate of 4.3% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 5.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROG Roche HoldingCHF 274.903.0%
+CHF 6.4b		11.4%PE20.6x
NOVN NovartisCHF 90.261.2%
+CHF 2.1b		-2.9%PE16.9x
LONN Lonza GroupCHF 591.004.9%
+CHF 2.0b		36.0%PE74.5x
ALC AlconCHF 80.623.4%
+CHF 1.3b		24.0%PE37.9x
STMN Straumann HoldingCHF 130.804.9%
+CHF 972.6m		-3.0%PE72.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GALD

CHF 109.78

Galderma Group

7D

3.5%

1Y

n/a

ASCN

CHF 3.25

Ascom Holding

7D

-21.7%

1Y

-56.0%

ROG

CHF 274.90

Roche Holding

7D

3.0%

1Y

11.4%

ALC

CHF 80.62

Alcon

7D

3.4%

1Y

24.0%

We Ran A Stock Scan For Earnings Growth And Alcon (VTX:ALC) Passed With Ease

Jan 22
We Ran A Stock Scan For Earnings Growth And Alcon (VTX:ALC) Passed With Ease

SOON

CHF 319.70

Sonova Holding

7D

5.1%

1Y

15.7%

XLS

CHF 24.00

Xlife Sciences

7D

-0.4%

1Y

-50.5%

NOVN

CHF 90.26

Novartis

7D

1.2%

1Y

-2.9%

STMN

CHF 130.80

Straumann Holding

7D

4.9%

1Y

-3.0%

The Price Is Right For Straumann Holding AG (VTX:STMN)

Dec 30
The Price Is Right For Straumann Holding AG (VTX:STMN)

IDIA

CHF 0.73

Idorsia

7D

-5.8%

1Y

-51.7%

Improved Revenues Required Before Idorsia Ltd (VTX:IDIA) Stock's 71% Jump Looks Justified

Dec 19
Improved Revenues Required Before Idorsia Ltd (VTX:IDIA) Stock's 71% Jump Looks Justified

KURN

CHF 21.30

Kuros Biosciences

7D

-3.8%

1Y

304.9%

Kuros Biosciences AG's (VTX:KURN) 27% Share Price Plunge Could Signal Some Risk

Dec 13
Kuros Biosciences AG's (VTX:KURN) 27% Share Price Plunge Could Signal Some Risk

BSLN

CHF 39.35

Basilea Pharmaceutica

7D

-1.4%

1Y

15.9%

METN

CHF 992.00

Metall Zug

7D

-2.7%

1Y

-31.6%

At CHF1,140, Is Metall Zug AG (VTX:METN) Worth Looking At Closely?

Dec 03
At CHF1,140, Is Metall Zug AG (VTX:METN) Worth Looking At Closely?

LONN

CHF 591.00

Lonza Group

7D

4.9%

1Y

36.0%

Market Participants Recognise Lonza Group AG's (VTX:LONN) Earnings

Nov 29
Market Participants Recognise Lonza Group AG's (VTX:LONN) Earnings

CURN

CHF 13.05

Curatis Holding

7D

-4.0%

1Y

n/a

SDZ

CHF 42.89

Sandoz Group

7D

4.3%

1Y

45.6%

VBSN

CHF 150.00

IVF Hartmann Holding

7D

-1.3%

1Y

38.9%